Few serum proteins mediate APOE's association with dementia

PLoS ONE

Volumn 12, Issue 3, 2017, Pages

  Royall, Donald R ^a,b,c   Al Rubaye, Safa ^a   Bishnoi, Ram ^d   Palmer, Raymond F ^b  

^a University of Texas Health Science Center   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c Texas Children's Hospital   (United States)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; AMPHIREGULIN; APOLIPOPROTEIN E; C REACTIVE PROTEIN; PLASMA PROTEIN;

AGE; AGED; ALLELE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; EDUCATIONAL STATUS; ETHNIC DIFFERENCE; FEMALE; GENDER; GENOTYPE; GERIATRIC DEPRESSION SCALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; NERVE DEGENERATION; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGED; APOLIPOPROTEINS E; BLOOD PROTEINS; DEMENTIA; HUMANS;

EID: 85015398569     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0172268     Document Type: Article

References (56)

1. Gavett BE, Vudy V, Jeffrey M, John SE, Gurnani A, Adams J. The δ latent dementia phenotype in the NACC UDS: Cross-validation and extension. Neuropsychology. 2015; 29:344-352. https://doi.org/10. 1037/neu0000128 PMID: 25151112
2. Palmer RF, Royall DR. Future Dementia Status is Almost Entirely Explained by the Latent Variable δ's Intercept and Slope. Journal of Alzheimer's Disease. 2016; 49:521-529. https://doi.org/10.3233/JAD-150254 PMID: 26444763
3. Spearman C, Wynn Jones LL. Human Ability, Macmillan & Co., London, 1951.
4. Royall DR, Palmer RF. Thrombopoietin is associated with δ's intercept, and only in Non-Hispanic Whites. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2016; 3:35-42.
5. Gavett BE, John SE, Gurnani A, Bussell CA, Saurman JL. The role of Alzheimer's and cerebrovascular pathology in mediating the effects of age, race, and apolipoprotein E genotype on dementia severity in pathologically confirmed Alzheimer's disease. Journal of Alzhiemer's Disease. 2016; 49:531-545.
6. Bishnoi R, Palmer RF, Royall DR. IL-15 as a serum biomarker of Alzheimer disease. PLoS ONE, 2015; 10:e0117282.
7. Bishnoi R, Palmer RF, Royall DR. Vitamin D binding protein as a serum biomarker of Alzheimer disease. Journal of Alzheimer's Disease. 2015; 43:37-45. https://doi.org/10.3233/JAD-140042 PMID: 25079796
8. Royall DR, Palmer RF. Ethnicity Moderates Dementia's Biomarkers. Journal of Alzheimer's Disease. 2015; 43:275-287. https://doi.org/10.3233/JAD-140264 PMID: 25079802
9. Yeo RA, Arden R, Jung RE. Alzheimer's disease and intelligence. Current Alzheimer Research. 2011; 8;345-353. PMID: 21222590
10. Lyall DM, Harris SE, Bastin ME, Munoz Maniega S, Murray C, Lutz MW, et al. Are APOE ϵ genotype and TOMM40 poly-T repeat length associations with cognitive ageing mediated by brain white matter tract integrity? Translational Psychiatry. 2014; 4,e449. https://doi.org/10.1038/tp.2014.89 PMID: 25247594
11. Wechsler D. Wechsler Memory Scale-Third Edition. San Antonio, TX: The Psychological Corporation, 1997.
12. Benton A, Hamsher K. Multilingual Aphasia Examination. AJA Associates, Iowa City, Iowa, 1989.
13. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969; 9:179-186. PMID: 5349366
14. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. British Journal of Psychiatry. 1982; 140:566-572. PMID: 7104545
15. Waring S, O'Bryant SE, Reisch JS, Diaz-Arrastia R, Knebl J, Doody R, for the Texas Alzheimer's Research Consortium. The Texas Alzheimer's Research Consortium longitudinal research cohort: Study design and baseline characteristics. Texas Public Health Journal. 2008; 60:9-13.
16. Koch W, Ehrenhaft A, Griesser K, Pfeufer A, Muller J, Schomig A, et al. TaqMan systems for genotyping of disease-related polymorphisms present in the gene encoding apolipoprotein E. Clinical Chemistry and Laboratory Medicine. 2002; 40:1123-1131. https://doi.org/10.1515/CCLM.2002.197 PMID: 12521230
17. Arbuckle JL. Analysis of Moment Structures-AMOS ( Version 7.0) [Computer Program], SPSS, Chicago, 2006.
18. Grice JW. Computing and evaluation factor scores. Psychological Methods. 2001; 6:430-450. PMID: 11778682
19. Kraemer HC, Stice E, Kazdin A, Offord D, Kupfer D. How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. American Journal of Psychiatry. 2001; 158:848-856. https://doi.org/10.1176/appi.ajp.158.6.848 PMID: 11384888
20. MacKinnon D. Analysis of mediating variables in prevention and intervention research. In: Czarees A, Beatty L (editors). Scientific methods for prevention intervention research. NIDA Research Monograph. 1994; 139:137-153.
21. Metz CE. Basic principles of ROC analysis. Seminars in Nuclear Medicine. 1978; 8:283-298. PMID: 112681
22. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine. Clinical Chemistry. 1993; 39:561-577. PMID: 8472349
23. Palmer RF, Royall DR. Missing data? Plan on it! Journal of the American Geriatric Society. 2010; 58: S343-348.
24. Schafer JL, Graham JW. Missing data: Our view of the state of the art. Psychological Methods. 2002; 7:147-177. PMID: 12090408
25. Graham JW. Missing Data Analysis: Making it work in the real world. Annual Review of Psychology. 2009; 6:549-576.
26. PASW Statistics 18, Release Version 18.0.0, SPSS, Inc., 2009, Chicago, IL.
27. Bollen KA, Long JS. Testing Structural Equation Models. Sage Publications, Thousand Oaks, CA, 1993.
28. Wheaton B, Muthen B, Alwin DF, Summer GF. Assessing reliability and stability in panel models. In Heise D.R. (Ed.) Sociology Methodology San Francisco, CA: Jossey-Bass, 1977.
29. Bentler PM. Comparative fit indexes in structural models. Psychological Bulletin. 1990; 107:238-246. PMID: 2320703
30. Browne M, Cudeck R. Alternative ways of assessing model fit. In Testing structural equation models, Bollen KA, Long JS, eds. Sage Publications, Thousand Oaks, CA, pp. 136-162, 1993.
31. Royall DR, Palmer RF, Vidoni ED, Honea RA, Burns JM. The Default Mode Network and related right hemisphere structures may be the key substrates of dementia. Journal of Alzheimer's Disease. 2012; 32:467-478. https://doi.org/10.3233/JAD-2012-120424 PMID: 22842866
32. Chetelat G, Fouquet M. Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers. Revue Neurologique (Paris). 2013; 169:729-736.
33. Buckner RL, Sepulcre J, Talukdar T, Krienen FM, Liu H, Hedden T, et al. Cortical Hubs Revealed by Intrinsic Functional Connectivity: Mapping, Assessment of Stability, and Relation to Alzheimer's Disease. Journal of Neuroscience. 2009; 29:1860-1873. https://doi.org/10.1523/JNEUROSCI.5062-08. 2009 PMID: 19211893
34. Shi J, Han P, Kuniyoshi SM. Cognitive impairment in neurological diseases: lessons from apolipoprotein E. Journal of Alzheimer's Disease. 2014; 38;1-9. https://doi.org/10.3233/JAD-130623 PMID: 23948926
35. Wolters FJ, Koudstaal PJ, Hofman A, van Duijn CM, Ikram MA. Serum apolipoprotein E is associated with long-term risk of Alzheimer's disease: The Rotterdam Study. Neuroscience Letters. 2016;23: 617:139-42. https://doi.org/10.1016/j.neulet.2016.02.018 PMID: 26876448
36. Morgan AR, Touchard S, O'Hagan C, Sims R, Majounie E, Escott-Price V, et al. The correlation between inflammatory biomarkers and polygenic risk score in Alzheimer's Disease. Journal of Alzheimer's Disease. 2016; in press.
37. Royall DR, Al-Rubaye S, Bishnoi R, Palmer RF. Serum protein biomarkers of δ fully mediate multiple AD conversion risks and offer targets for intervention [abstract]. Journal of Prevention of Alzheimer's Disease. 2016; 3,283.
38. Lima TA, Adler AL, Minett T, Matthews FE, Brayne C, Marioni RE, Medical Research Council Cognitive Function and Aging Study. Age & Aging 2014; 43:289-292.
39. Metti AL, Yaffe K, Boudreau RM, Simonsick EM, Carnahan RM, Satterfield S, et al., Health ABC Study. Trajectories of inflammatory markers and cognitive decline over 10 years. Neurobiology of Aging 2014; 35:2785-2790. https://doi.org/10.1016/j.neurobiolaging.2014.05.030 PMID: 24997674
40. Haan MN, Aiello AE, West NA, Jagust WJ. C-reactive protein and rate of dementia in carriers and noncarriers of apolipoprotein APOE4 genotype. Neurobiology of Aging 2008; 29:1774-1782. https://doi. org/10.1016/j.neurobiolaging.2007.04.020 PMID: 17540481
41. Austin MA, Zhang C, Humphries SE, Chandler WL, Talmud PJ, Edwards KL, et al. Heritability of C-reactive protein and association with apolipoprotein E genotypes in Japanese-Americans. Annals of Human Genetics. 2004; 68:179-188. https://doi.org/10.1046/j.1529-8817.2004.00078.x PMID: 15180698
42. Hubacek JA, Peasey A, Pikhart H, Stavek P, Kubinova R, Marmot M, et al. APOE polymorphism and its effect on plasma C-reactive protein levels in a large general population sample. Human Immunology. 2010; 71:304-308. https://doi.org/10.1016/j.humimm.2010.01.008 PMID: 20074603
43. Chu AY, Guilianini F, Barratt BJ, Nyberg F, Chasman DI, Ridker PM. Pharmacogenetic determinants of statin-induced reductions in C-reactive protein. Circlaoty and Cardiovascular Genetics. 2012; 5:58-565. https://doi.org/10.1161/CIRCGENETICS.111.961847 PMID: 22230323
44. US Food and Drug Administration (2012, February 28). FDA drug safety communication: Important safety label changes to cholesterol-lowering statin drugs. http://www.fda.gov/Drugs/DrugSafety/ ucm293101.htm.
45. Sharma M, Fitzpatrick AL, Arnold AM, Chi G, Lopez OL, Jenny NS, et al. Inflammatory biomarkers and cognitive decline: The Ginkgo Evaluation of Memory Study. Journal of the American Geriatrics Society 2016; 64:1171-1177. https://doi.org/10.1111/jgs.14140 PMID: 27321596
46. Novak U, Walker F, Kaye A. Expression of EGFR-family proteins in the brain: role in development, health and disease. Journal of Clinical Neuroscience 2001; 8:106-111.
47. Gavett BE, John SE, Gurnani AS, Bussell CA, Saurman JL. The role of Alzheimer's and cerebrovascular pathology in mediating the effects of age, race, and apolipoprotein E genotype on dementia severity in pathologically confirmed Alzheimer's disease. Journal of Alzhiemer's Disease 2016; 49:531-545.
48. Carlson JO, Gatz M, Pedersen NL, Graff C, Nennesmo I, Lindstrom AK, et al. Antemortem Prediction of Braak Stage Journal of Neuropathology & Experimental Neurology 2015; 74,1061-1070.
49. Falk A, Frisen J. Amphiregulin is a mitogen for adult neural stem cells. Journal of Neuroscience Research. 2002; 69:757-762. https://doi.org/10.1002/jnr.10410 PMID: 12205669
50. Kleiman T, Zdanys K, Black B, Rightmer T, Grey M, Garman K, et al. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis. Dementia Geriatric and Cognitive Disorders. 2006; 22:73-82.
51. Tucker-Drob EM, Briley DA, Starr JM, Deary IJ. Structure and correlates of cognitive aging in a narrow age cohort. Psychology of Aging 2014; 29:236-249.
52. Davies G, Armstrong N, Bis JC, Bressler J, Chouraki V, Giddaluru S, et al. Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N = 53949). Molecular Psychiatry. 2015; 20:183-192. https://doi.org/10.1038/mp.2014.188 PMID: 25644384
53. Khachaturian AS, Corcoran CD, Mayer LS, Zandi PP, Breitner JC. Cache County Study Investigators. Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study. Archives of General Psychiatry. 2004; 61:518-524. https://doi.org/10.1001/ archpsyc.61.5.518 PMID: 15123497
54. Song H, Long H, Zuo X, Yu C, Liu B, Wang Z, et al. APOE effects on Default Mode Network in Chinese cognitively normal elderly: Relationship with clinical cognitive performance. PLoS One. 2015; 10: e0133179. https://doi.org/10.1371/journal.pone.0133179 PMID: 26177270
55. Su YY, Liang X, Schoepf UJ, Varga-Szemes A, West HC, Qi R, et al. APOE polymorphism affects brain Default Mode Network in healthy young adults: A STROBE article. Medicine (Baltimore). 2015; 94: e1734.
56. Calderon-Garciduenas L, Mora-Tiscareno A, Franco-Lira M, Zhu H, Lu Z, Solorio E, et al. Decreases in Short Term Memory, IQ, and Altered Brain Metabolic Ratios in Urban Apolipoprotein ϵ4 Children Exposed to Air Pollution. Journal of Alzheimers Disease. 2015; 45:757-770.